TORONTO -- (MARKET WIRE) -- March 13, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has expanded its patent coverage with newly issued patents in Canada and Europe issued by the Canadian Intellectual Property Office and the European Patent office, respectively.
